← 홈

CGT

1,235개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologicPoseida Therapeutics, Inc.Phase 2

autologous anti-BCMA chimeric antigen receptor T cells (autologous anti-BCMA chimeric antigen receptor T cells)

ITP · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 97.1%임상시험 47상태 ACTIVE
CGTBiologicVaxcell Bio, Co., Ltd.Phase 1

Autologous Natural Killer Cell Therapy (Autologous Natural Killer Cell Therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 14%임상시험 46상태 RECRUITING
CGTBiologicstaleBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Non-small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#세포유전치료#CAR-T+4
임상시험 46상태 ACTIVE
CGTBiologicFondazione Policlinico Universi…deruxtecan, have shown clin…Preclinical

Cell function identification (Cell function identification)

Bronchiolitis Obliterans Syndrome (BOS) · Bronchiolitis Obliterans Syndrome (BOS)

#BronchiolitisObliteransSyndromeB#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 46상태 ACTIVE
CGTBiologicCenter for International Blood …Phase 2

Chronic Myeloid Leukemia + NK cell (Chronic Myeloid Leukemia + NK cell)

Chronic Myeloid Leukemia · Chronic Myeloid Leukemia

#ChronicMyeloidLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 46상태 ACTIVE
CGTBiologicstaleGeneplus-Beijing Co. Ltd.Phase 2

DC-CIK (DC-CIK)

Renal Cell Carcinoma · Renal Neoplasma

#RenalNeoplasma#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 46상태 ACTIVE
CGTBiologicWuhan Sian Medical Technology C…Phase 2

Second generation CAR-T cells (Second generation CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 46상태 ACTIVE
CGTBiologicstaleHistograft Co., Ltd.operatedPreclinical

"Histograft", a bone substitute based on octacalcium phosphate (OCP, "Histograft", a bone substitute based on octacalcium phosphate, "Histograft", a bone substitute based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA gene)

Non Union Fracture; Non-Union of Ankle Joint Without Infection · FRα

#FR#CGT#Preclinical#세포유전치료#CAR-T+5
임상시험 45상태 ACTIVE
CGTBiologicstaleAcrotech Biopharma Inc.Vedotin, and BelinostatPhase 1

Belinostat (Belinostat)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 25%임상시험 45상태 DISCONTINUED
CGTBiologicstaleSecuraBio-deliveringPhase 3

Duvelisib (Duvelisib)

Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma · FRα

#FR#CGT#Phase3#세포유전치료#CAR-T+5
효능 ORR 82%임상시험 45상태 RECRUITING
CGTBiologicMerck Sharp & Dohme LLCPhase 2

Letermovir (Letermovir)

Relapsed Refractory Multiple Myeloma (RRMM) · Cell Therapy

#CellTherapy#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 45상태 RECRUITING
CGTBiologicstaleNovartisPhase 3

tisagenlecleucel (Kymriah, tisa-cel)

Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase3#세포유전치료#CAR-T+4
효능 ORR 83.3%임상시험 45상태 DISCONTINUED
CGTBiologicstaleIncyte CorporationPhase 2

pentostatin (pentostatin)

Chronic Myeloproliferative Disorders; Leukemia · Chronic Myeloproliferative Disorders

#ChronicMyeloproliferativeDisorde#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 96%임상시험 45상태 DISCONTINUED
CGTBiologicGuangzhou FineImmune Biotechnol…Phase 1

tumor-specific TCR-T cells (tumor-specific TCR-T cells)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 50%임상시험 45상태 RECRUITING
CGTBiologicstaleInnovative Cellular Therapeutic…calicheamicin, may impact C…Phase 2

CART-19 (CART-19)

Acute Lymphocytic Leukemia · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 43.8%임상시험 44상태 ACTIVE
CGTBiologicstaleThe Methodist Hospital Research…Phase 2

gene therapy (ADV/HSV-tk, ADV/HSV-tk (gene therapy))

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 4%임상시험 42상태 RECRUITING
CGTBiologicIncyte CorporationPhase 2

Immune effector cell therapy (Immune effector cell therapy)

Cytokine Release Syndrome · Cytokine Release Syndrome

#CytokineReleaseSyndrome#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 41상태 ACTIVE
CGTBiologicstaleOHSU Knight Cancer InstitutePhase 2

Hyper-CVAD (Hyper-CVAD)

Relapsed/Refractory; B-cell Acute Lymphocytic Leukemia · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 89%임상시험 40상태 RECRUITING
CGTBiologicstaleViroMissile, Inc.foreignPhase 1

oncolytic vaccinia virus (IDOV-Immune, IDOV-Immune (oncolytic vaccinia virus))

Colorectal Cancer; Pancreatic Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#세포유전치료#CAR-T+5
효능 ORR 80%임상시험 40상태 RECRUITING
CGTBiologicstaleImmunityBio, Inc.Phase 2

haNK (haNK)

Melanoma · Merkel Cell Carcinoma

#MerkelCellCarcinoma#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 5%임상시험 40상태 DISCONTINUED

7 / 62 페이지

← 이전다음 →